Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgery Insight: surgical methods to reverse left ventricular remodeling.

Michele De Bonis1, Ottavio Alfieri

  • 1Department of Cardiac Surgery at San Raffaele University Hospital, Milan, Italy. debonis.michele@hsr.it

Nature Clinical Practice. Cardiovascular Medicine
|August 26, 2006
PubMed
Summary

Surgical interventions can help manage congestive heart failure (CHF) by reversing left ventricular remodeling, a key predictor of mortality. Advanced therapies like gene and cell therapy show promise for future heart failure treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Reverse Saddle Mitral Annulus Shape Explains Apparent Systolic Mitral Annular Disjunction in Mitral Valve Prolapse: A Three-Dimensional Transesophageal Echocardiography Analysis.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2026
Same author

Mitral Annular Disjunction: A Roadmap for the Surgeon.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2025
Same author

Long-term outcomes of bioprosthetic tricuspid valves: a systematic review of studies published over the last 20 years.

European heart journal. Imaging methods and practice·2025
Same author

Outcomes of left ventricular assist device implantation following previous mitral transcatheter edge-to-edge repair.

The International journal of artificial organs·2025
Same author

Real-world outcomes of TMVR-eligible and TMVR-ineligible patients.

European heart journal. Imaging methods and practice·2025
Same author

Left ventricular ejection fraction and benefit of tricuspid valve interventions - insights from the international TRIGISTRY.

European journal of heart failure·2025

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Management

Background:

  • Congestive heart failure (CHF) presents significant management challenges with high mortality rates.
  • Left ventricular dilatation is a primary predictor of mortality in CHF patients.
  • Medical therapy alone often yields suboptimal outcomes for advanced heart failure.

Purpose of the Study:

  • To review common surgical techniques aimed at reversing left ventricular remodeling in CHF.
  • To discuss the role of surgical interventions in improving outcomes for heart failure patients.
  • To explore emerging innovative therapies for heart failure treatment.

Main Methods:

  • Review of current surgical procedures for CHF, including myocardial revascularization, ventricular restoration, and mitral valve repair.

Related Experiment Videos

  • Discussion of ventricular assist devices and diastolic support systems.
  • Exploration of novel approaches such as gene therapy, cell therapy, and engineered tissues.

    • Main Results:

    • Surgical interventions address multiple pathophysiologic components of CHF, often requiring combined approaches.
    • Refined surgical techniques and accumulating data are expected to improve treatment outcomes.
    • Emerging therapies hold potential for significant future advancements in heart failure management.

    Conclusions:

    • Surgical management is crucial for reversing left ventricular remodeling in CHF.
    • A combination of surgical procedures is frequently necessary for comprehensive heart failure treatment.
    • Future innovations in regenerative medicine and tissue engineering offer hope for improved CHF therapies.